Pegfilgrastim Pregnancy and Breastfeeding Warnings
Pegfilgrastim is also known as: Neulasta
Pegfilgrastim Pregnancy Warnings
Pegfilgrastim has been assigned to pregnancy category C by the FDA. Studies in pregnant rabbits have shown adverse effects with doses of 50 mcg/kg/dose, an amount approximately 4-fold higher than the recommended human dose. Doses of 200 to 250 mcg/kg/dose of filgrastim resulted in an increased incidence of abortions. Subcutaneous injections of pegfilgrastim of up to 1000 mcg/kg/dose administered every other day during the period of organogenesis in rats were not associated with an embryotoxic or fetotoxic outcome. There are no controlled data in human pregnancy. Pegfilgrastim is only recommended for use during pregnancy when benefit outweighs risk.
Pegfilgrastim Breastfeeding Warnings
There are no data on the excretion of pegfilgrastim into human milk. The manufacturer recommends that caution be used when administering pegfilgrastim to nursing women.
See Also...
- pegfilgrastim Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
